Canada markets close in 6 hours 8 minutes

Catalyst Biosciences, Inc. (CBIO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.7600-0.0100 (-0.56%)
As of 09:51AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 56.34M
Enterprise Value 23.44M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)8.44
Price/Book (mrq)2.08
Enterprise Value/Revenue 3.52
Enterprise Value/EBITDA -0.29

Trading Information

Stock Price History

Beta (5Y Monthly) 1.90
52-Week Change 3-57.86%
S&P500 52-Week Change 3-12.09%
52 Week High 35.2000
52 Week Low 30.3500
50-Day Moving Average 31.0054
200-Day Moving Average 31.4603

Share Statistics

Avg Vol (3 month) 36.74M
Avg Vol (10 day) 33.41M
Shares Outstanding 531.48M
Implied Shares Outstanding 6N/A
Float 822.73M
% Held by Insiders 125.09%
% Held by Institutions 131.36%
Shares Short (Jun 14, 2022) 41.47M
Short Ratio (Jun 14, 2022) 40.09
Short % of Float (Jun 14, 2022) 44.72%
Short % of Shares Outstanding (Jun 14, 2022) 44.68%
Shares Short (prior month May 12, 2022) 4158.35k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Feb 12, 2017
Ex-Dividend Date 4Aug 19, 2015
Last Split Factor 21:15
Last Split Date 3Feb 12, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022


Profit Margin 0.00%
Operating Margin (ttm)-1,125.12%

Management Effectiveness

Return on Assets (ttm)-58.82%
Return on Equity (ttm)-122.02%

Income Statement

Revenue (ttm)6.67M
Revenue Per Share (ttm)0.21
Quarterly Revenue Growth (yoy)-45.90%
Gross Profit (ttm)-64.91M
EBITDA -74.63M
Net Income Avi to Common (ttm)-80.03M
Diluted EPS (ttm)-2.5480
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)34.82M
Total Cash Per Share (mrq)1.11
Total Debt (mrq)1.91M
Total Debt/Equity (mrq)7.05
Current Ratio (mrq)2.78
Book Value Per Share (mrq)0.86

Cash Flow Statement

Operating Cash Flow (ttm)-71.45M
Levered Free Cash Flow (ttm)-39.04M